Literature DB >> 15334500

Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1.

Joost Frenkel, Marjan J A van Kempen, Wietse Kuis, Hans Kristian Ploos van Amstel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15334500     DOI： 10.1002/art.20295

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

Review 1.  [Genetics of cryopyrin-associated periodic syndrome].

Authors:  J B Kümmerle-Deschner; P Lohse
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

Review 2.  Genetic and molecular basis of inflammasome-mediated disease.

Authors:  Hal M Hoffman; Susannah D Brydges
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 3.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

4.  A novel CIAS1mutation in a Japanese patient with chronic infantile neurological cutaneous and articular syndrome.

Authors:  Hidetoshi Takada; Koichi Kusuhara; Akihiko Nomura; Shouichi Ohga; Mikiko Hayashi; Masutaka Furue; Toshiro Hara
Journal:  Eur J Pediatr       Date:  2005-08-27       Impact factor: 3.183

5.  Extracellular Inflammasome Particles Are Released After Marathon Running and Induce Proinflammatory Effects in Endothelial Cells.

Authors:  Alexander Kogel; Sven Fikenzer; Luisa Uhlmann; Lena Opitz; Jasmin M Kneuer; Karl Georg Haeusler; Matthias Endres; Jürgen Kratzsch; Viktoria Schwarz; Christian Werner; Hermann Kalwa; Susanne Gaul; Ulrich Laufs
Journal:  Front Physiol       Date:  2022-05-20       Impact factor: 4.755

6.  The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.

Authors:  Ivona Aksentijevich; Christopher D Putnam; Hal M Hoffman; Daniel L Kastner; Elaine F Remmers; James L Mueller; Julie Le; Richard D Kolodner; Zachary Moak; Michael Chuang; Frances Austin; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2007-04

7.  NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22.

Authors:  Marianne R Spalinger; Stephanie Kasper; Claudia Gottier; Silvia Lang; Kirstin Atrott; Stephan R Vavricka; Sylvie Scharl; Tina Raselli; Isabelle Frey-Wagner; Petrus M Gutte; Markus G Grütter; Hans-Dietmar Beer; Emmanuel Contassot; Andrew C Chan; Xuezhi Dai; David J Rawlings; Florian Mair; Burkhard Becher; Werner Falk; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  J Clin Invest       Date:  2016-04-04       Impact factor: 14.808

Review 8.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives.

Authors:  Ema Ozaki; Matthew Campbell; Sarah L Doyle
Journal:  J Inflamm Res       Date:  2015-01-16

9.  Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.

Authors:  Jenny Mae Samson; Dinoop Ravindran Menon; Prasanna K Vaddi; Nazanin Kalani Williams; Joanne Domenico; Zili Zhai; Donald S Backos; Mayumi Fujita
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

10.  Monocarboxylate Transporter 4 Triggered Cell Pyroptosis to Aggravate Intestinal Inflammation in Inflammatory Bowel Disease.

Authors:  Yaodong Wang; Xiaorong Zhou; Kejian Zou; Guanhua Chen; Ling Huang; Fangying Yang; Wenxu Pan; Hongwei Xu; Zhaohui Xu; Huan Chen; Jiayu Chen; Sitang Gong; Xuan Zhou; Wanfu Xu; Junhong Zhao
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.